Brittany Livingston LCSW-C, LICSW

Recommended Articles

• Wrestler Marti Belle's Battle Against Alzheimer's Is Something Personal

  Marti Belle is just one of the women in the world who has proven that women can not only be strong, but powerful as well. In fact, she is the first female wrestler of Dominican descent in WWE history, and for her, one of her greatest honors is being able to represent Latinas in wrestling.Belle was...

• Revealing your Breast Cancer Diagnosis to Your Loved Ones

  Finding out that you have cancer is probably one of the worst things to happen to a person. The news of any illness is very discomforting news. However, the word cancer alone holds a great deal of power if you will. In terms of diseases based on common knowledge, cancer is at the top of the worst....

• Support Groups for Muscular Dystrophy: Finding Genuine Connection and Understanding

  A lot of people are suffering from muscular dystrophy (MD). The most common forms of MD in children are Duchenne and Becker, and about 400 to 500 boys are born with these in the United States each year. About 70,000 people in the UK suffer from MD. This condition, which is usually acquired by people...

• The Effects of AIDS on Families

   IntroductionAIDS negatively affects not only the person suffering from it but also their families. It affects the relationships of the patients' family members. One major effect of HIV on families is the stress on children. Children often feel stress just knowing one of their family members has an...

• Airforce Veteran Finds Joy in Being a Nurse

  Jonathan Haag turned his life around after a life-changing injury and used his experience to became a nurse. Jonathan went through a condition that still affects him today, but he is much stronger now and uses his experiences to heal those around him. Jonathan has an incredible story of hope,...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...